rs2748543
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001393334.1(CIDEB):c.-1052G>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.15 in 152,280 control chromosomes in the GnomAD database, including 2,367 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.15 ( 2366 hom., cov: 32)
Exomes 𝑓: 0.082 ( 1 hom. )
Consequence
CIDEB
NM_001393334.1 5_prime_UTR
NM_001393334.1 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.422
Genes affected
CIDEB (HGNC:1977): (cell death inducing DFFA like effector b) Enables identical protein binding activity. Involved in activation of cysteine-type endopeptidase activity; positive regulation of cell death; and positive regulation of release of cytochrome c from mitochondria. Acts upstream of or within apoptotic process. Located in cytosol and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
LTB4R2 (HGNC:19260): (leukotriene B4 receptor 2) Predicted to enable G protein-coupled peptide receptor activity and leukotriene B4 receptor activity. Predicted to be involved in inflammatory response and neuropeptide signaling pathway. Predicted to act upstream of or within keratinocyte migration and signal transduction. Located in nucleoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.267 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CIDEB | NM_001393334.1 | c.-1052G>T | 5_prime_UTR_variant | Exon 2 of 7 | NP_001380263.1 | |||
CIDEB | NM_001318807.3 | c.-414-638G>T | intron_variant | Intron 2 of 7 | NP_001305736.1 | |||
CIDEB | NM_001393335.1 | c.-447-638G>T | intron_variant | Intron 1 of 6 | NP_001380264.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CIDEB | ENST00000258807.5 | c.-414-638G>T | intron_variant | Intron 1 of 6 | 1 | ENSP00000258807.5 | ||||
LTB4R2 | ENST00000528054 | c.-1104C>A | 5_prime_UTR_variant | Exon 1 of 1 | ENSP00000432146.1 | |||||
CIDEB | ENST00000336557.9 | c.-414-638G>T | intron_variant | Intron 2 of 7 | 2 | ENSP00000337731.5 | ||||
LTB4R2 | ENST00000527924.6 | c.-95-703C>A | intron_variant | Intron 1 of 2 | 3 | ENSP00000436668.2 |
Frequencies
GnomAD3 genomes AF: 0.150 AC: 22852AN: 152052Hom.: 2365 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
22852
AN:
152052
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0818 AC: 9AN: 110Hom.: 1 Cov.: 0 AF XY: 0.0972 AC XY: 7AN XY: 72 show subpopulations
GnomAD4 exome
AF:
AC:
9
AN:
110
Hom.:
Cov.:
0
AF XY:
AC XY:
7
AN XY:
72
Gnomad4 AFR exome
AF:
AC:
0
AN:
6
Gnomad4 AMR exome
AC:
0
AN:
0
Gnomad4 ASJ exome
AC:
0
AN:
0
Gnomad4 EAS exome
AF:
AC:
0
AN:
4
Gnomad4 SAS exome
AC:
0
AN:
0
Gnomad4 FIN exome
AF:
AC:
3
AN:
12
Gnomad4 NFE exome
AF:
AC:
5
AN:
80
Gnomad4 Remaining exome
AF:
AC:
1
AN:
8
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.150 AC: 22857AN: 152170Hom.: 2366 Cov.: 32 AF XY: 0.147 AC XY: 10914AN XY: 74384 show subpopulations
GnomAD4 genome
AF:
AC:
22857
AN:
152170
Hom.:
Cov.:
32
AF XY:
AC XY:
10914
AN XY:
74384
Gnomad4 AFR
AF:
AC:
0.041177
AN:
0.041177
Gnomad4 AMR
AF:
AC:
0.273917
AN:
0.273917
Gnomad4 ASJ
AF:
AC:
0.188184
AN:
0.188184
Gnomad4 EAS
AF:
AC:
0.00192976
AN:
0.00192976
Gnomad4 SAS
AF:
AC:
0.105558
AN:
0.105558
Gnomad4 FIN
AF:
AC:
0.131967
AN:
0.131967
Gnomad4 NFE
AF:
AC:
0.204633
AN:
0.204633
Gnomad4 OTH
AF:
AC:
0.162072
AN:
0.162072
Heterozygous variant carriers
0
958
1916
2874
3832
4790
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
244
488
732
976
1220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
193
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at